Results 21 to 30 of about 12,086 (222)
Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke. [PDF]
Cell Mol Neurobiol, 2020 Stroke continues to be one of the leading causes of mortality and morbidity worldwide. Restoration of cerebral blood flow by recombinant plasminogen activator (rtPA) with or without mechanical thrombectomy is considered the most effective therapy for ...
Kadir RRA, Bayraktutan U.
europepmc +3 more sources
Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent [PDF]
Atom Indonesia, 2012 Stroke and acute myocardial infarction is a disease with the highest mortality in the world. WHO has estimated in 2008, 30% of deaths from heart disease and more than 80% of this cases have been occurred in developing countries.
I. Daruwati +3 more
doaj +3 more sources
Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers [PDF]
Journal of Research in Pharmacy Practice, 2012 Objective: Coronary artery disease is one of the leading causes of morbidity and mortality in populations. In opium abusers, level of circulating coagulation factors differs from non-abusers. The aim of this study was to evaluate response to thrombolytic
Seyed Mohammad Hashemi Jazi +2 more
doaj +1 more source
Optimization of Postoperative Analgesia during Traumatic Interventions in Angiologic Care
Общая реаниматология, 2010 Objective: to search for a procedure for drug injection into the pulmonary artery to enhance the efficiency of thrombolytic therapy. Subjects and methods. Twenty patients with submassive unilateral pulmonary thromboembolism were examined.
S. I. Sitkin
doaj +1 more source
Assessing safety of thrombolytic therapy [PDF]
, 2017 Thrombolytic therapy involves thrombolytic agents administered to patients suffering from venous or arterial thrombosis. The therapy induces systemic effects interrelated with the thrombolytic agent used.
Gram, Jørgen Brodersen +2 more
core +1 more source
Neuromodulation: Technology at the Neural Interface, EarlyView., 2021 Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone +8 more
wiley +1 more source
Anistreplase: A Novel Thrombolytic Agent for Acute Myocardial Infarction [PDF]
, 1990 Anistreplase, a modified congener of streptokinase, is a recently approved thrombolytic agent used in the treatment of acute myocardial infarction (AMI).
Jacqueline S. Marinac +2 more
core +1 more source
Ultrasound-accelerated catheter-assisted thrombolytic therapy applicatıons in deep vein thrombosis. [PDF]
, 2019 Ultrasound-accelerated catheter-directed thrombolysis (UCT) increases the invasion of thrombolytic agent into the thrombus using ultrasonic energy, provides less infusion of thrombolytic agent, reduces complication, and post-thrombotic syndrome (PTS ...
M Arslan +17 more
core +1 more source
Endovascular Treatment of Cerebral Venous Sinus Thrombosis
Pediatric Neurology Briefs, 2013 Investigators at Frenchay Hospital, Bristol, UK, retrospectively reviewed case notes and imaging in 9 consecutive children (age range 18 months to 16 years) with cerebral venous sinus thrombosis (CVST) who were treated using endovascular methods after ...
J Gordon Millichap
doaj +1 more source
Frontiers in Bioengineering and Biotechnology, 2022 There is a need to improve the efficacy and safety of endovascular techniques in venous thrombotic diseases, and microbubble enhanced sonothrombolysis is a promising approach.
Zhaojian Wang +10 more
doaj +1 more source